MD5Y - Method for eliminating the dislocation of the intraocular lens - Google Patents

Method for eliminating the dislocation of the intraocular lens Download PDF

Info

Publication number
MD5Y
MD5Y MDS20080014A MDS20080014A MD5Y MD 5 Y MD5 Y MD 5Y MD S20080014 A MDS20080014 A MD S20080014A MD S20080014 A MDS20080014 A MD S20080014A MD 5 Y MD5 Y MD 5Y
Authority
MD
Moldova
Prior art keywords
dislocation
eliminating
lens
intraocular lens
solution
Prior art date
Application number
MDS20080014A
Other languages
Romanian (ro)
Inventor
Ion Jeru
Original Assignee
Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova filed Critical Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority to MDS20080014A priority Critical patent/MD5Z/en
Publication of MD5Y publication Critical patent/MD5Y/en
Publication of MD5Z publication Critical patent/MD5Z/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Inventia se refera la oftalmologie, in special la o metoda de inlaturare a dislocarii cristalinului artificial. Esenta inventiei consta in aceea caconcomitent se administreaza subconjunctival 0,3 ml de solutie de Mezaton 1%, intravenos 2,0 ml deFurosemid si per os 0,25 mg de Diacarb, apoi peste 30 min in conditii obscure la iluminarea directa a corneei cu oftalmoscopul se aplica o presiune cu microspatula in regiunea limbului, si anume pe meridianul dislocarii ansei cristalinului pana la repozitia ei sub iris, dupa care se administreaza subconjunctival o picatura de solutie de Pilocarpina 1%. The invention relates to ophthalmology, in particular to a method of removing artificial crystalline dislocation. The essence of the invention lies in the fact that 0.3 ml of Mezaton 1% solution is administered subconjunctivally, intravenously 2.0 ml of Furosemid and 0.25 mg of Diacarb per bone, then over 30 minutes under dark conditions under direct illumination of the cornea with the ophthalmoscope a pressure with the microspatula is applied in the region of the tongue, ie on the meridian of the displacement of the lens of the lens until its replacement under the iris, after which a drop of 1% Pilocarpine solution is administered subconjunctivally.

MDS20080014A 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens MD5Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20080014A MD5Z (en) 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20080014A MD5Z (en) 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens

Publications (2)

Publication Number Publication Date
MD5Y true MD5Y (en) 2009-02-28
MD5Z MD5Z (en) 2009-09-30

Family

ID=45094332

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20080014A MD5Z (en) 2008-07-17 2008-07-17 Method for eliminating the dislocation of the intraocular lens

Country Status (1)

Country Link
MD (1) MD5Z (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (en) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for donor blood testing for hepatitis B virus markers
  • 2008
    • 2008-07-17 MD MDS20080014A patent/MD5Z/en not_active IP Right Cessation

Also Published As

Publication number Publication date
MD5Z (en) 2009-09-30

Similar Documents

Publication Publication Date Title
EA201000441A1 (en) AQUATIC OPHTHALMIC PREPARATIONS
CO6351718A2 (en) SUPPLY OF SUSTAINED RELEASE OF ACTIVE AGENTS TO TREAT GLAUCOMA AND OCULAR HYPERTENSION
EA201071413A1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF INCREASE IN-PRESSURE AND GLAUCOMA
JP2009501726A (en) Ophthalmologically active agent formulations and methods of administration thereof
WO2007101016A3 (en) Small diameter inlays
SG10201903210WA (en) Sunitinib Formulations and Methods for Use Thereof in Treatment of Ocular Disorders
RU2017139870A (en) NEW NPR-B AGONISTS
US9987254B2 (en) Ophthalmic composition for correcting presbyopia
Ritch Natural compounds: evidence for a protective role in eye disease
MX2018001918A (en) PERIORBITAL QUANTITATIVE APPLICATION OF OPHTHALMOLOGICAL PHARMACOS.
RU2012126028A (en) LOCAL EYE PEPTIDE COMPOSITION
US20150164635A1 (en) Method of Reducing the Occurrence of Macular and Neuroretinal Degenerations by Alleviating Age Related Retinal Stresses as a Contributing Factor in a Mammalian Eye
ES2964629T3 (en) Eye drops with citric acid as the only active ingredient
MD5Y (en) Method for eliminating the dislocation of the intraocular lens
MX2022013665A (en) HETERODIMER COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISORDERS.
US20170007637A1 (en) Pharmacological ophthalmic composition for use in the correction of presbyopia and its administration
CA2905594A1 (en) Compositions for use in treating eye disorders using dipyridamole
Furino et al. Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration
NZ622403A (en) Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method
KR20250067950A (en) Formulations comprising chelators, permeation enhancers and hydroxyethyl cellulose for treating ophthalmic disorders
WO2010047803A3 (en) A method for the treatment of proliferative disorders of the eye
WO2007075720A3 (en) Topical mecamylamine formulations for ocular administration and uses thereof
Gandorfer Pathology and Implications for Surgery
RU2642731C1 (en) Method for surgical management of open-angle glaucoma in patients with pseudophakia
US20140275124A1 (en) Methods for treating eye disorders using dipyridamole

Legal Events

Date Code Title Description
FG9Y Short term patent issued
MK4Y Short term patent expired